TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancerFelicity E. B. May, Bruce R. Westley|Endocrine Related Cancer|2015Cited by 56
Increased expression of both insulin receptor substrates 1 and 2 confers increased sensitivity to IGF-1 stimulated cell migrationGail E de Blaquière, Bruce R. Westley|Endocrine Related Cancer|2009Cited by 20